These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14989190)

  • 1. DHHS issues adult guideline revisions.
    Bartlett JG;
    Hopkins HIV Rep; 2004 Jan; 16(1):1, 5. PubMed ID: 14989190
    [No Abstract]   [Full Text] [Related]  

  • 2. How HIV drugs work 101.
    Pietrandoni G
    Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
    [No Abstract]   [Full Text] [Related]  

  • 3. Consider these initial combination regimens.
    AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
    [No Abstract]   [Full Text] [Related]  

  • 4. ABC in the news.
    Carter M
    IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
    [No Abstract]   [Full Text] [Related]  

  • 5. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

  • 6. The ever-changing HIV treatment landscape.
    Berger DS
    Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
    [No Abstract]   [Full Text] [Related]  

  • 7. Protease inhibitors in children: combination therapy reduced death by two thirds.
    James JS
    AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease inhibitor boosting is complex, requires thorough knowledge of interactions.
    Monier P
    HIV Clin; 2004; 16(3):1-3. PubMed ID: 15366104
    [No Abstract]   [Full Text] [Related]  

  • 9. Teaching adherence to substance users.
    TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV's potent cocktail.
    Lusky K
    Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
    [No Abstract]   [Full Text] [Related]  

  • 11. Protease inhibitors: opium of the masses?
    Martinez LJ
    Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplifying suppression: switching therapies to improve HIV disease management.
    Moyle GJ
    AIDS Read; 2004 Jul; 14(7):380-4. PubMed ID: 15282867
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral update.
    PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV infections: mortality reduced only in developed countries].
    Wehr A
    Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
    [No Abstract]   [Full Text] [Related]  

  • 15. Report from ICAAC: new drugs and antiretroviral therapy for naïve patients.
    Gallant JE
    Hopkins HIV Rep; 2002 Nov; 14(6):1-3, 7. PubMed ID: 12491989
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Introduction.
    TreatmentUpdate; 2003; 15(3):1. PubMed ID: 17216843
    [No Abstract]   [Full Text] [Related]  

  • 17. New versions of antiretroviral guidelines contain some important changes.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
    [No Abstract]   [Full Text] [Related]  

  • 18. Report from the 12th Retrovirus Conference. Adherence.
    Friedland GH; Nagy GS
    AIDS Clin Care; 2005 Apr; 17(4):36. PubMed ID: 15875309
    [No Abstract]   [Full Text] [Related]  

  • 19. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes.
    Albrecht H
    J Watch AIDS Clin Care; 2009 Oct; 21(10):82. PubMed ID: 20458813
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
    TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.